Staar Surgical Swings to $0.38 EPS Profit After Year-Ago $0.52 Loss
Staar reported Q1 EPS of $0.38, beating the $0.13 consensus and swinging from a year-ago loss of $0.52 per share. It issued a shareholder letter alongside first-quarter results highlighting operational advances and regained profitability.
1. Q1 Financial Performance
Staar Surgical reported Q1 adjusted EPS of $0.38, surpassing the $0.13 consensus and reversing a $0.52 loss from Q1 2025. Revenue growth outpaced expectations on stronger intraocular collamer lens demand and disciplined cost controls.
2. Shareholder Letter Highlights
The company issued a shareholder letter with its quarterly report, outlining strategic priorities such as expanding global distribution channels, advancing its R&D pipeline and pursuing operational efficiencies to sustain profitability.
Related News
WMT
Walmart Set for Q1 EPS of $0.66 on $175B Revenue; Value Outlook Tempered
WMT•
MKL
Markel Appoints Danny O’Donoghue, 15-Year Fine Art & Specie Underwriter, to Lead London Unit
MKL•
MA
Chargebacks911 Partners with acceptcards to Reduce Chargebacks as UK Card Use Tops £1 Trn
MA•
LOW
Lowe's Q1 Profit Falls to $1.62 Billion as Revenues Surge 10.3% to $23.07 Billion
LOW•
ODV
Osisko Development Raises US$275M via 4.125% Convertible Notes with 25% Premium
ODV•
Sources
ZBZF